Clinical trial
Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma (PAP-OP)
NCT06115772 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma (PAP-OP)
- Lead sponsor
- Mayo Clinic
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- November 1, 2022
- Completion date
- November 1, 2027
- Enrollment
- 154 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
oropharyngeal human papillomavirus-positive squamous cell carcinoma